DexCom, Inc. - Common Stock (NQ:DXCM)

86.90 +1.54 (+1.80%)

Delayed Quote Updated: 4:00 PM EDT, Oct 5, 2026 Add to My Watchlist

Quote

Overview Detailed Quote Charting Historical Prices

News

All News News Headlines Press Releases

Research

Quarterly Reports Insider Filings Other Filings

All News about DexCom, Inc. - Common Stock

< Previous 1 2 3 4 5 6 7 8 9

...

50 51 Next >

DexCom (DXCM) Stock Trades Down, Here Is Why

January 08, 2026

Shares of medical device company DexCom (NASDAQ:DXCM) fell 2.6% in the morning session after analysts at Piper Sandler and Bernstein lowered their price targets on the stock, citing concerns over the...

Via StockStory

Topics Artificial Intelligence

Dexcom Enters Next Era of Continued Innovation With Jake Leach as President and Chief Executive Officer

January 07, 2026

From DexCom, Inc.

Via Business Wire

3 Nasdaq 100 Stocks Worth Your Attention

January 04, 2026

The Nasdaq 100 (^NDX) is where investors find some of the most innovative and disruptive companies shaping the future. A select few continue to execute at a high level, growing their market dominance...

Via StockStory

The Evolution of a Healthcare Giant: Abbott Laboratories (ABT) 2026 Stock Feature

January 01, 2026

As of today, January 1, 2026, Abbott Laboratories (NYSE: ABT) stands as one of the most resilient and strategically diversified giants in the global healthcare landscape. While the broader market has...

Via PredictStreet

Topics Economy Lawsuit World Trade

2 Healthcare Stocks for Long-Term Investors and 1 We Find Risky

December 31, 2025

Personal health and wellness is one of the many secular tailwinds for healthcare companies. Players catalyzing medical advancements have benefited from elevated demand, which has supported the...

Via StockStory

Topics Stocks

2 Growth Stocks to Buy For 2026 and Beyond ↗

December 30, 2025

Neither had a great year in 2025, but the future is looking bright.

Via The Motley Fool

Topics Economy

DexCom Inc (NASDAQ:DXCM) Embodies the Growth at a Reasonable Price (GARP) Strategy ↗

December 30, 2025

DexCom (DXCM) exemplifies Growth at a Reasonable Price (GARP) with strong double-digit earnings growth, solid profitability, and a valuation justified by its industry-leading position in diabetes...

Via Chartmill

DEXCOM CLASS ACTION DEADLINE ALERT: Bragar Eagel & Squire, P.C. Reminds DXCM Investors of the December 26th Deadline for Contacting the Firm

December 26, 2025

From Bragar Eagel & Squire

Via GlobeNewswire

DXCM Investors Have Opportunity to Lead DexCom, Inc. Securities Fraud Lawsuit with the Schall Law Firm

December 26, 2025

From Schall Law

Via GlobeNewswire

The $65 Billion Pulse: How Wearable AI and Telemedicine are Redefining the Future of Healthcare

December 24, 2025

The convergence of consumer technology and clinical medicine has reached a fever pitch as 2025 draws to a close. A landmark report released this December by ResearchAndMarkets.com projects that the...

Via MarketMinute

Topics Artificial Intelligence

1 Cash-Heavy Stock for Long-Term Investors and 2 We Avoid

December 22, 2025

Companies with more cash than debt can be financially resilient, but that doesn’t mean they’re all strong investments. Some lack leverage because they struggle to grow or generate consistent profits,...

Via StockStory

DEXCOM CLASS ACTION DEADLINE ALERT: Bragar Eagel & Squire, P.C. Reminds DXCM Investors of the December 26th Deadline for Contacting the Firm

December 22, 2025

From Bragar Eagel & Squire

Via GlobeNewswire

DXCM Deadline in 4 Days: Kessler Topaz Meltzer & Check, LLP Reminds DexCom, Inc. (DXCM) Investors of Filing Deadline in Class Action Lawsuit

December 22, 2025

Via TheNewswire.com

Topics Lawsuit

DXCM Deadline in 4 Days: Kessler Topaz Meltzer & Check, LLP Reminds DexCom, Inc. (DXCM) Investors of Filing Deadline in Class Action Lawsuit

December 22, 2025

Search for the latest press releases from publicly traded companies, private corporations, non-profits and other public sector organizations.

Via NewMediaWire

Topics Lawsuit

DXCM Investors Have Opportunity to Lead DexCom, Inc. Securities Fraud Lawsuit with the Schall Law Firm

December 22, 2025

From Schall Law

Via GlobeNewswire

SHAREHOLDER ALERT Bernstein Liebhard LLP Announces A Securities Fraud Class Action Lawsuit Has Been Filed Against DexCom, Inc. (NASDAQ: DXCM)

December 22, 2025

From Bernstein Liebhard LLP

Via GlobeNewswire

DexCom Inc (NASDAQ:DXCM): A High-Growth Stock Forming a Bullish Technical Setup ↗

December 19, 2025

DexCom (DXCM) combines strong growth fundamentals with a promising technical breakout setup, offering a potential entry point for investors.

Via Chartmill

1 Cash-Producing Stock with Impressive Fundamentals and 2 We Ignore

December 18, 2025

While strong cash flow is a key indicator of stability, it doesn’t always translate to superior returns. Some cash-heavy businesses struggle with inefficient spending, slowing demand, or weak...

Via StockStory

Halper Sadeh LLC Encourages DexCom, Inc. Shareholders to Contact the Firm to Discuss Their Rights

December 18, 2025

Shareholders should contact the firm immediately as there may be limited time to enforce your rights

From Halper Sadeh LLC

Via GlobeNewswire

DXCM DEADLINE ALERT: Kessler Topaz Meltzer & Check, LLP Announces Deadline in Dexcom, Inc. (DXCM) Securities Fraud Class Action Lawsuit

December 18, 2025

Search for the latest press releases from publicly traded companies, private corporations, non-profits and other public sector organizations.

Via NewMediaWire

Topics Fraud Lawsuit

DXCM DEADLINE ALERT: Kessler Topaz Meltzer & Check, LLP Announces Deadline in Dexcom, Inc. (DXCM) Securities Fraud Class Action Lawsuit

December 18, 2025

Via TheNewswire.com

Topics Fraud Lawsuit

DXCM Investors Have Opportunity to Lead DexCom, Inc. Securities Fraud Lawsuit with the Schall Law Firm

December 18, 2025

From Schall Law

Via GlobeNewswire

SHAREHOLDER ALERT Bernstein Liebhard LLP Announces A Securities Fraud Class Action Lawsuit Has Been Filed Against DexCom, Inc. (NASDAQ: DXCM)

December 17, 2025

From Bernstein Liebhard LLP

Via GlobeNewswire

Bragar Eagel & Squire, P.C. Reminds Investors That Class Action Lawsuits Have Been Filed Against DexCom and CarMax and Encourages Investors to Contact the Firm

December 16, 2025

From Bragar Eagel & Squire

Via GlobeNewswire

DXCM DEADLINE: ROSEN, TRUSTED INVESTOR COUNSEL, Encourages DexCom, Inc. Investors to Secure Counsel Before Important December 29 Deadline in Securities Class Action – DXCM

December 16, 2025

From The Rosen Law Firm PA

Via GlobeNewswire

“Buying the Dip” in 2025: A Strategy Rewarded, But Future Requires Caution and Diversification

December 16, 2025

December 16, 2025 – The "buying the dip" investment strategy, which involves purchasing an asset after its price has declined with the anticipation of a subsequent recovery, has seen significant...

Via MarketMinute

Topics Artificial Intelligence Economy

DXCM INVESTOR ALERT: Bronstein, Gewirtz & Grossman, LLC Announces That DexCom, Inc. Investors With Substantial Losses Have Opportunity to Lead Class Action Lawsuit

December 15, 2025

Search for the latest press releases from publicly traded companies, private corporations, non-profits and other public sector organizations.

Via NewMediaWire

Topics Lawsuit

DXCM INVESTOR ALERT: Bronstein, Gewirtz & Grossman, LLC Announces That DexCom, Inc. Investors With Substantial Losses Have Opportunity to Lead Class Action Lawsuit

December 15, 2025

Via TheNewswire.com

Topics Lawsuit

DXCM Investors Have Opportunity to Lead DexCom, Inc. Securities Fraud Lawsuit with the Schall Law Firm

December 15, 2025

From Schall Law

Via GlobeNewswire

DEXCOM, INC. (NASDAQ: DXCM) DEADLINE ALERT Bernstein Liebhard LLP Reminds DexCom, Inc. Investors of Upcoming Deadline

December 15, 2025

From Bernstein Liebhard LLP

Via GlobeNewswire

< Previous 1 2 3 4 5 6 7 8 9

...

50 51 Next >

Stock Quote API & Stock News API supplied by www.cloudquote.io. Quotes delayed at least 20 minutes. Market data may be delayed. Research information, not personalized advice.